Divi's Laboratories Ltd

DIVISLAB

Company Profile

  • Business description

    Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.

  • Contact

    Cyber Hills
    Divi Towers, 1-72/23(P)/DIVIS/303
    Gachibowli
    HyderabadTG500032
    IND

    T: +91 4066966300

    https://www.divislabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    9,109

Stocks News & Analysis

stocks

Cheap e-commerce share continues sales momentum

The e-commerce business continues its sales momentum despite challenging backdrop.
stocks

Chart of the Week: Booming mined commodity prices see little value on offer

Iran War disruptions drive thermal coal and aluminum prices higher but value to be found in other pockets.
stocks

3 ASX top picks to combat inflation

The mechanics behind inflation resilient ASX businesses.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,819.6065.10-0.73%
CAC 408,207.8934.780.43%
DAX 4025,177.807.09-0.03%
Dow JONES (US)50,644.28182.600.36%
FTSE 10010,502.003.01-0.03%
HKSE25,002.29325.94-1.29%
NASDAQ26,674.7318.550.07%
Nikkei 22564,693.12306.29-0.47%
NZX 50 Index13,206.1121.70-0.16%
S&P 5007,520.361.240.02%
S&P/ASX 2008,592.9061.60-0.71%
SSE Composite Index4,097.643.910.10%

Market Movers